Oral Contraceptives (OCPs) |
- Usually tried as initial therapy |
- Limited success due to the progesterone component of OCPs |
|
- Fewer side effects than other most other therapies |
|
Antihistamines |
- Well tolerated, few side effects |
- Rarely effective as monotherapy |
|
|
- Does not address underlying mechanism |
Conjugated Estrogens |
- Avoids progesterone component of OCPs |
- Increased risk of endometrial cancer, not commonly used today |
|
|
- Often require high doses |
Glucocorticoids |
- Able to suppress multiple components of the immune system |
- Usually not effective alone |
|
- Can be combined with other therapies |
- Often require high doses |
GnRH Agonists |
- Often used if OCPs and glucocorticoids are not effective |
- Can cause symptoms of estrogen deficiency (hot flashes, decreased bone mineral density) |
Alkaylated Steroids |
- Can be combined with low dose steroids |
- Can cause symptoms of excess androgens (facial hair, hepatic dysfunction, mood disorders) |
|
- Interferes with gonadal hormone receptors |
|
Tamoxifen |
- Has been used successfully in patients unresponsive to conjugated estrogen |
- Can cause symptoms of estrogen deficiency |
|
|
- Increased risk of venous thrombosis and cataract formation |
Bilateral oopherectomy |
- Definitive treatment, used if medical options unsuccessful |
- Surgical procedure, associated morbidity |
|
|
- Symptoms of estrogen deficiency |